These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25575079)

  • 1. Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
    Silva M; Daheron L; Hurley H; Bure K; Barker R; Carr AJ; Williams D; Kim HW; French A; Coffey PJ; Cooper-White JJ; Reeve B; Rao M; Snyder EY; Ng KS; Mead BE; Smith JA; Karp JM; Brindley DA; Wall I
    Cell Stem Cell; 2015 Jan; 16(1):13-7. PubMed ID: 25575079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Induced Pluripotent Stem Cells in Defined Three-Dimensional Hydrogels.
    Caiazzo M; Tabata Y; Lutolf MP
    Methods Mol Biol; 2017; 1612():65-78. PubMed ID: 28634935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
    Rivera T; Zhao Y; Ni Y; Wang J
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
    Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
    Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells.
    Yang W; Liu Y; Slovik KJ; Wu JC; Duncan SA; Rader DJ; Morrisey EE
    PLoS One; 2015; 10(8):e0134995. PubMed ID: 26281015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA.
    Umrath F; Steinle H; Weber M; Wendel HP; Reinert S; Alexander D; Avci-Adali M
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse.
    Woltjen K; Kim SI; Nagy A
    Methods Mol Biol; 2016; 1357():1-22. PubMed ID: 26126450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
    Graversen VK; Chavala SH
    Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.
    Kwon D; Ji M; Lee S; Seo KW; Kang KS
    Stem Cell Rev Rep; 2017 Feb; 13(1):24-34. PubMed ID: 27817181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines.
    Steeg R; Mueller SC; Mah N; Holst B; Cabrera-Socorro A; Stacey GN; De Sousa PA; Courtney A; Zimmermann H
    Stem Cell Reports; 2021 Aug; 16(8):1853-1867. PubMed ID: 34380020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
    Lieu PT
    Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immune response on the use of iPSCs in disease modeling.
    Zhang Z; Huang B; Gao F; Zhang R
    Curr Stem Cell Res Ther; 2015; 10(3):236-44. PubMed ID: 25019961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of Neural Stem Cells from Mouse Induced Pluripotent Stem Cells.
    Karanfil I; Bagci-Onder T
    Methods Mol Biol; 2016; 1357():329-38. PubMed ID: 25863785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
    Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
    Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
    Han MJ; Kim HR; O'Reilly C; Kim CH
    Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human iPSC line by mRNA reprogramming.
    Artero Castro A; León M; Del Buey Furió V; Erceg S; Lukovic D
    Stem Cell Res; 2018 Apr; 28():157-160. PubMed ID: 29499498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
    Sun C; Wilson GS; Fan JG; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.